Company intelligence / Profile preview

Prxcision

Schenectady, New York, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

The pRxcision platform provides real-time, evidence-based antibiotic regimen recommendations by integrating patient-specific clinical and microbiological data and optimizing for antimicrobial exposure and stewardship. No clinical trial data as this is a software/AI platform, but platform is commercially deployed.

Therapeutic areas: Infectious Diseases
Industry: Digital Health Medical Devices

Partnerships

T2 Biosystems (for integrated AI diagnostics and decision support)

Beyond the preview

Go deeper on Prxcision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prxcision.

Explore the full profile